/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Mark Fereshteh

Genmab (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

81

Papers

2.2K

Citations

17

h-index

20

i10-index

Mark Fereshteh is an academic researcher from Genmab (United States). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 17, co-authored 69 publications.

Research Topics

Cancer Immunotherapy and Biomarkers HER2/EGFR in Cancer Research Monoclonal and Polyclonal Antibodies Research Estrogen and related hormone effects CAR-T cell therapy research

Papers by this author

works

The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for <i>Neu</i> (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

2008 · Cancer Research · 97 citations

https://doi.org/10.1158/0008-5472.can-07-6702

Mark Fereshteh Maddalena T. Tilli Sung Eun Kim Jianming Xu

Research topics

topics

Cancer Immunotherapy and Biomarkers

HER2/EGFR in Cancer Research

Monoclonal and Polyclonal Antibodies Research

Estrogen and related hormone effects

CAR-T cell therapy research

Chat about Author

Papers

Chat

Click to start Chat